Morgan Stanley
Profile

BLUEWAVE Technologies

2019 Multicultural Innovation Lab Cohort

BLUEWAVE Technologies is a venture backed healthtech startup and creator of the BLUEWAVE, a device designed to kill bacteria* and viruses** with its proprietary ozone infusion technology. It is a dry, room-temperature process using no water, detergents, or added chemicals. The device is closed-loop and removes excess ozone upon completing the treatment. In the testing conducted to date, the BLUEWAVE device kills 99.999% and 99.91% of MS2 Bacteriophage Virus, a non-enveloped virus, in under 10 minutes on stainless steel surfaces and 2-ply porous polyester fabric, respectively.

BLUEWAVE Technologies’ founding team is augmented by advisors and investors including Morgan Stanley’s Multicultural Innovation Lab, a former EVP and President of Global Healthcare at Ecolab, a former CFO of Brown-Forman, and other industry experts.

* At this time, efficacy of the device has been evaluated against the MRSA bacterium

**At this time, efficacy of the device has been evaluated against the MS2 Bacteriophage virus

Quick Facts

Co-Founder and President: Justin Zhou

Headquarters: Orange City, Florida

Industry: Health Care Hardware

Website (or App): www.mybluewave.com

Learn More About the Innovation Lab